David Thickett

Prof

Accepting PhD Students

PhD projects

David Thickett’s research interests are predominantly in the areas of primary lung epithelial and macrophage biology, murine models of acute lung injury, epithelial mesenchymal transition and translational clinical trials to prevent and treat acute lung injury and idiopathic pulmonary fibrosis. He has been and continues to be a co-investigator or principal investigator on a number of clinical trials successfully obtaining an MRC DCS grant for 2 clinical trials of vitamin D therapy to prevent lung injury following oesophagectomy. Dr Thickett is currently involved in the following studies: Translational science lead, chairman of clinical endpoints committee and steering group member for BALTI- PREVENTION PI of a phase II trial of simvastatin in healthy elderly patients PI of a phase II study of the pharmcogenetics of vitamin D replacement in tuberculosis PI of a phase II open label dosing study of vitamin D following oesophagectomy The PI of a phase II study vitamin D to prevent acute lung injury following oesophagectomy (VINDALOO)

19972022

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Fingerprint

Dive into the research topics where David Thickett is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Network

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or